D. Saller

发表

Committee Opinion No. 690: Carrier Screening in the Age of Genomic Medicine.

J. Biggio, D. Saller, 2017, Obstetrics and gynecology.

Maternal Cell free DNA based screening for fetal microdeletion and the importance of careful diagnostic follow up

A. Rajkovic, T. Chu, D. Saller, 2014, Genetics in Medicine.

Reproductive outcomes in individuals with chromosomal reciprocal translocations

U. Surti, A. Rajkovic, D. Saller, 2021, Genetics in Medicine.

Genotype–phenotype correlation and pregnancy outcomes of partial trisomy 14q: A systematic review

U. Surti, A. Rajkovic, D. Saller, 2016, American journal of medical genetics. Part A.

Current Methods of Prenatal Screening for Down Syndrome and Other Fetal Abnormalities

J. Canick, D. Saller, 2008, Clinical obstetrics and gynecology.

Risk‐based prenatal screening for trisomy 18 using alpha‐fetoprotein, unconjugated oestriol and human chorionic gonadotropin

J. Canick, D. Luthy, N. Wald, 1995, Prenatal diagnosis.

Second‐Trimester Maternal Serum Placental Growth Factor and Vascular Endothelial Growth Factor for Predicting Severe, Early‐Onset Preeclampsia

D. Saller, R. Mooney, C. Cox, 2003, Obstetrics and gynecology.

THE RELATIONSHIP BETWEEN SECOND‐TRIMESTER AMNIOTIC FLUID INSULIN AND GLUCOSE LEVELS AND SUBSEQUENT GESTATIONAL DIABETES

J. Canick, G. Palomaki, C. Sung, 1997, Prenatal diagnosis.

Ultrasonography estimates of fetal growth in fetuses affected by trisomy 21

D. Saller, J. Catov, T. Canavan, 2016, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Brachydactyly-short stature-hypertension (Bilginturan) syndrome: report on two families.

G. Bresnick, D. Rimoin, D. Chitayat, 1997, American journal of medical genetics.

Detection and quantification by homogeneous PCR of cell-free fetal DNA in maternal plasma.

D. Saller, J. W. Sutherland, C. Wei, 2001, Clinical chemistry.

Second‐trimester levels of maternal urinary gonadotropin peptide in down syndrome pregnancy

R. Osathanondh, J. Canick, G. Palomaki, 1995, Prenatal diagnosis.

Investigating Pregnancy Outcomes After Abnormal Cell-Free DNA Test Results

D. Saller, Beatrice A. Chen, Jessica Lu, 2018, Journal of Genetic Counseling.

Screening for Fetal Aneuploidy: Is Maternal Age Relevant?

D. Saller, A. Hawk, Angela F. Hawk, 2012, Clinical obstetrics and gynecology.

Do Women Grieve After Terminating Pregnancies Because of Fetal Anomalies? A Controlled Investigation

D. Saller, M. Rosenblatt, J. V. Dailey, 1993, Obstetrics and gynecology.

Prenatal screening for Down syndrome: current and future methods.

J. Canick, G. Lambert-Messerlian, D. Saller, 2003, Clinics in laboratory medicine.

Second‐trimester maternal serum analyte levels associated with fetal trisomy 13

J. Canick, J. Haddow, G. Palomaki, 1999, Prenatal diagnosis.

Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome.

J. Canick, M. Blitzer, D. Saller, 1992, American journal of obstetrics and gynecology.

Prenatal screening for Down's syndrome with use of maternal serum markers.

J. Canick, J. Haddow, G. Knight, 1992, The New England journal of medicine.

Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection

J. Canick, D. Saller, B. Rogers, 1993, Prenatal diagnosis.

The clinical utility of the perinatal autopsy.

D. Saller, B. Rogers, K. Lesser, 1995, JAMA.

Cytogenetic abnormalities among perinatal deaths demonstrating a single umbilical artery

D. Saller, R. Neiger, 1994, Prenatal diagnosis.

Expansion of phenotype and genotypic data in CRB2-related syndrome

A. Fulton, D. Schneidman-Duhovny, A. Rajkovic, 2016, European Journal of Human Genetics.

Prenatal whole‐exome sequencing: parental attitudes

A. Rajkovic, D. Saller, A. Althouse, 2015, Prenatal diagnosis.

Copy number alterations involving 59 ACMG‐recommended secondary findings genes

U. Surti, D. Bellissimo, A. Rajkovic, 2020, Clinical genetics.

Cytogenetic signatures of recurrent pregnancy losses

A. Rajkovic, J. Yanowitz, D. Saller, 2020, medRxiv.

Beyond Down syndrome phenotype: Paternally derived isodicentric chromosome 21 with partial monosomy 21q22.3

U. Surti, A. Rajkovic, D. Saller, 2017, American journal of medical genetics. Part A.

Second‐trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops

J. Canick, D. Saller, C. French, 1998, Prenatal diagnosis.

Tocolysis in the management of third trimester bleeding.

D. Saller, D. Nagey, M. Pupkin, 1990, Journal of perinatology : official journal of the California Perinatal Association.

Lupus anticoagulant

D. Saller, A. Malinow, B. Mokriski, 1987, Anaesthesia.

Importance of complete phenotyping in prenatal whole exome sequencing

Huaiyang Jiang, D. Bellissimo, A. Rajkovic, 2018, Human Genetics.

The association of single umbilical artery with cytogenetically abnormal pregnancies.

D. Saller, S. Schwartz, C. C. Sun, 1990, American journal of obstetrics and gynecology.

Serum Triple‐Marker Screening in In Vitro Fertilization and Naturally Conceived Pregnancies

J. Canick, D. Saller, J. Hogan, 1997, Obstetrics and gynecology.

Implications for obstetric anaesthetists

D. Saller, K. Mokrisk, 1987 .

Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha‐fetoprotein, unconjugated oestriol, and human chorionic gonadotropin

J. Canick, J. Haddow, G. Knight, 1992, Prenatal diagnosis.

Committee Opinion No. 691 Summary: Carrier Screening for Genetic Conditions.

J. Biggio, D. Saller, 2017, Obstetrics and gynecology.

Prenatal diagnosis of trisomy 6q25.3-qter and monosomy 10q26.12-qter by array CGH in a fetus with an apparently normal karyotype

A. Rajkovic, W. Parks, D. Saller, 2014, Clinical case reports.

Patient preferences for screening in the first trimester

D. Saller, E. Werner, L. Pastore, 2008, Prenatal diagnosis.

Genetic screening in a university clinic: impact of primary language

D. Saller, L. Pastore, A. Hawk, 2011, Prenatal diagnosis.

Second-Trimester Maternal Serum Alpha- Fetoprotein, Unconjugated Estriol, and hCG Levels in Pregnancies With Ventral Wall Defects

J. Canick, J. Haddow, G. Knight, 1994, Obstetrics and Gynecology.

Maternal serum analyte levels in pregnancies with fetal Down syndrome resulting from translocations.

J. Canick, D. Saller, R. Mooney, 1997, American journal of obstetrics and gynecology.

Decreased Maternal Serum hCG Levels With Increasing Gravidity and Parity

D. Saller, R. Mooney, C. French, 1995, Obstetrics and gynecology.

Maternal serum screening for fetal Down syndrome: the detection of other pathologies.

J. Canick, D. Saller, 1996, Clinical obstetrics and gynecology.

A normative study of obstetric complications associated with fetal trisomy 18.

J. Canick, D. Saller, J. Star, 1996, Journal of Perinatology.

Detection of parvovirus B19 DNA in amniotic fluid by PCR DNA amplification.

D. Saller, B. Rogers, G. Buffone, 1993, BioTechniques.

Maternal serum screening for fetal Down syndrome: clinical aspects.

J. Canick, D. Saller, 1996, Clinical obstetrics and gynecology.

Placental metastases in a patient with recurrent breast carcinoma.

D. Sherer, D. Saller, J. Sickel, 1994, American journal of obstetrics and gynecology.

Absent umbilical artery diastolic flow in a fetus with a partial mole at 18 weeks' gestation.

D. Sherer, D. Saller, L. Metlay, 1993, American journal of obstetrics and gynecology.

Second‐trimester maternal serum analyte levels associated with fetal trisomy 13

J. Canick, J. Haddow, G. Palomaki, 1999, Prenatal diagnosis.

Levels of urinary beta‐core fragment, total oestriol, and the ratio of the two in second‐trimester screening for Down syndrome

R. Osathanondh, J. Canick, G. Palomaki, 1997, Prenatal diagnosis.

Genetic screening in a university clinic: impact of primary language

D. Saller, L. Pastore, Angela F. Hawk, 2011, Prenatal diagnosis.

Second‐trimester maternal serum progesterone levels in Turner syndrome with and without hydrops and in trisomy 18

J. Canick, G. Lambert-Messerlian, D. Saller, 1999, Prenatal diagnosis.

Second‐trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops

J. Canick, G. Lambert-Messerlian, D. Saller, 1998, Prenatal diagnosis.